Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $582.72 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $101.14 | 6 | $0 (2023) |
| PFIZER INC. | $97.82 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $68.17 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $50.29 | 3 | $0 (2018) |
| Amgen Inc. | $50.09 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.84 | 2 | $0 (2023) |
| Novo Nordisk Inc | $26.40 | 2 | $0 (2017) |
| Dexcom, Inc. | $22.57 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $21.62 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $19.93 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $122.36 | 7 | Dexcom, Inc. ($22.57) |
| 2023 | $196.31 | 10 | PFIZER INC. ($69.13) |
| 2022 | $92.36 | 5 | GlaxoSmithKline, LLC. ($72.43) |
| 2021 | $28.69 | 1 | PFIZER INC. ($28.69) |
| 2020 | $12.83 | 1 | Genentech USA, Inc. ($12.83) |
| 2018 | $16.58 | 1 | Merck Sharp & Dohme Corporation ($16.58) |
| 2017 | $113.59 | 7 | AstraZeneca Pharmaceuticals LP ($34.68) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.66 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Gastroenterology | ||||||
| 08/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Endocrinology | ||||||
| 07/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Cardiology | ||||||
| 11/27/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Inflammation | ||||||
| 10/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: DIABETES | ||||||
| 10/05/2023 | PFIZER INC. | PREMARIN (Drug), DUAVEE | Food and Beverage | In-kind items and services | $35.14 | General |
| Category: WOMENS HEALTH | ||||||
| 09/13/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/11/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/27/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Inflammation | ||||||
| 03/25/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING | Food and Beverage | In-kind items and services | $33.99 | General |
| Category: WOMENS HEALTH | ||||||
| 03/15/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardio-renal | ||||||
| 03/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: RESPIRATORY | ||||||
| 02/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: RESPIRATORY | ||||||
| 10/26/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: PSYCHIATRY | ||||||
| 09/02/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: RESPIRATORY | ||||||
| 06/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: RESPIRATORY | ||||||
| 05/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: RESPIRATORY | ||||||
| 01/27/2021 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: VACCINES | ||||||
| 12/15/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Virology & Specialty Care | ||||||
| 10/04/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 405 | 561 | $59,837 | $32,940 |
| 2022 | 17 | 642 | 999 | $80,953 | $45,604 |
| 2021 | 10 | 448 | 794 | $58,674 | $33,136 |
| 2020 | 9 | 425 | 752 | $52,327 | $24,343 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 182 | $25,480 | $13,349 | 52.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $12,670 | $8,871 | 70.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 129 | $13,620 | $6,474 | 47.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 19 | $3,567 | $1,367 | 38.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 23 | 27 | $2,275 | $1,339 | 58.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $925.00 | $695.75 | 75.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 46 | 60 | $600.00 | $495.60 | 82.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $450.00 | $294.12 | 65.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 22 | 25 | $250.00 | $55.00 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 222 | $31,080 | $16,062 | 51.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $13,300 | $11,348 | 85.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 197 | $22,655 | $10,983 | 48.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $1,342 | $1,295 | 96.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,310 | $1,199 | 51.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 32 | $1,184 | $842.04 | 71.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 12 | 12 | $984.00 | $807.04 | 82.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 124 | 251 | $2,510 | $743.64 | 29.6% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 20 | 22 | $492.00 | $406.71 | 82.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 13 | $910.00 | $406.17 | 44.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 24 | 24 | $600.00 | $391.68 | 65.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 12 | 12 | $1,080 | $363.84 | 33.7% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2022 | 13 | 16 | $624.00 | $250.72 | 40.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 13 | $702.00 | $212.66 | 30.3% |
| 90471 | Administration of vaccine | Office | 2022 | 16 | 16 | $592.00 | $155.02 | 26.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 28 | 38 | $380.00 | $82.69 | 21.8% |
About Dr. John Dow, MD
Dr. John Dow, MD is a Family Medicine healthcare provider based in Trumann, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386605491.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Dow, MD has received a total of $582.72 in payments from pharmaceutical and medical device companies, with $122.36 received in 2024. These payments were reported across 32 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($582.72).
As a Medicare-enrolled provider, Dow has provided services to 1,920 Medicare beneficiaries, totaling 3,106 services with total Medicare billing of $136,023. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Trumann, AR
- Active Since 03/29/2006
- Last Updated 03/08/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386605491
Products in Payments
- TRELEGY ELLIPTA (Drug) $101.14
- PREMARIN (Drug) $69.13
- FARXIGA (Drug) $68.17
- Otezla (Drug) $34.83
- BELSOMRA (Drug) $33.71
- REXULTI (Drug) $33.59
- PREVNAR 13 (Biological) $28.69
- Dexcom G6 Transmitter (Medical Supply) $22.57
- LEQVIO (Drug) $21.62
- STIOLTO (Drug) $18.80
- Kerendia (Drug) $18.51
- YUPELRI (Drug) $18.24
- JANUVIA (Drug) $16.58
- Levemir (Drug) $15.27
- Repatha (Biological) $15.26
- XIFAXAN (Drug) $14.42
- CAPLYTA (Drug) $14.19
- JARDIANCE (Drug) $14.04
- Xofluza (Drug) $12.83
- Victoza (Drug) $11.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.